Free download: This guide is designed to introduce you to how genomics is being integrated into the clinic, what goes into using a patient’s DNA to reach a diagnosis, and how this information can be communicated to primary care physicians.
Efficiently translating genomic research into the clinic is one of the most important steps in the development of the field. The clinic is where we will see things come to fruition.
Home genetic tests like AncestryDNA and 23andMe are more popular than ever. But having widespread access to personal genetic information—without the knowledge of how to interpret results—can lead to problems.
Gilead Sciences has announced some promising results from one of its pre-clinical trials, which could be instrumental in the treatment of HIV.
Dame Sally Davies insists that learning more about a patient’s genetic makeup will lead to a better and more cost-effective approach, that will ultimately spare resources in the system.
The FDA has announced a plan to modernise its approach to evaluating new drugs for Alzheimer’s and other neurologic diseases.
Designed to accelerate pre-clinical genomic research and drug discovery for the benefit of patients, the team behind the global genomic data marketplace has grown by nearly 50% in the past year.
Helix has successfully closed a $200 million financing round, and has revealed that it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics.
Drugmakers are racing to secure health records and strike deals with technology companies, all to discover how medicines perform in the real world.
AstraZeneca has made the decision to push six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.
GenomeAsia 100k are trying to close the genetic gap that exists in the South Asian population, by seeking to sequence 100 genomes from the region.